scholarly article | Q13442814 |
P356 | DOI | 10.1586/14760584.2013.824708 |
P8608 | Fatcat ID | release_gpp5re42vzcwbgjjdyipsqdf6e |
P698 | PubMed publication ID | 24053399 |
P2093 | author name string | Christian Schulz | |
Sven Hammerschmidt | |||
P2860 | cites work | Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species | Q21184102 |
Genome of the Bacterium Streptococcus pneumoniae Strain R6 | Q22065464 | ||
Complete Genome Sequence of a Virulent Isolate of Streptococcus pneumoniae | Q22065841 | ||
Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines | Q24679117 | ||
Pneumococcal carbohydrate transport: food for thought | Q26830554 | ||
Recent advances in pneumococcal peptidoglycan biosynthesis suggest new vaccine and antimicrobial targets | Q27009118 | ||
Structure of the catalytic domain ofStreptococcus pneumoniaesialidase NanA | Q27651923 | ||
Glyceraldehyde-3-phosphate dehydrogenase of Streptococcus pneumoniae is a surface-displayed plasminogen-binding protein | Q40705348 | ||
The phosphoproteome of the minimal bacterium Mycoplasma pneumoniae: analysis of the complete known Ser/Thr kinome suggests the existence of novel kinases | Q40796719 | ||
Characterization of central carbon metabolism of Streptococcus pneumoniae by isotopologue profiling | Q41229544 | ||
Comparative phosphoproteomics reveals evolutionary and functional conservation of phosphorylation across eukaryotes | Q42123804 | ||
The pneumococcal eukaryotic-type serine/threonine protein kinase StkP co-localizes with the cell division apparatus and interacts with FtsZ in vitro | Q43132784 | ||
Distribution and genetic diversity of the ABC transporter lipoproteins PiuA and PiaA within Streptococcus pneumoniae and related streptococci. | Q43182325 | ||
Phosphoproteomic analysis reveals the multiple roles of phosphorylation in pathogenic bacterium Streptococcus pneumoniae | Q43247100 | ||
A Streptococcus pneumoniae pathogenicity island encoding an ABC transporter involved in iron uptake and virulence | Q43612695 | ||
alpha-Enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface | Q43666217 | ||
Early predictors of mortality in pneumococcal bacteraemia | Q43801991 | ||
Risk of red queen dynamics in pneumococcal vaccine strategy. | Q44253252 | ||
Immunological fingerprinting of group B streptococci: From circulating human antibodies to protective antigens | Q44592867 | ||
Constitutive expression of PcsB suppresses the requirement for the essential VicR (YycF) response regulator in Streptococcus pneumoniae R6. | Q44677363 | ||
Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community | Q44700585 | ||
Tissue-specific contributions of pneumococcal virulence factors to pathogenesis | Q45101885 | ||
Characterization of a eukaryotic type serine/threonine protein kinase and protein phosphatase of Streptococcus pneumoniae and identification of kinase substrates. | Q45273413 | ||
The Ser/Thr/Tyr phosphoproteome of Lactococcus lactis IL1403 reveals multiply phosphorylated proteins | Q46453903 | ||
Streptococcus pneumoniae: proteomics of surface proteins for vaccine development | Q46885129 | ||
Tigecycline: an expanded broad-spectrum intravenous antibiotic. Preface and summary | Q46906135 | ||
Pneumococcal neuraminidase A: an essential upper airway colonization factor for Streptococcus pneumoniae. | Q48452515 | ||
Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. | Q51748961 | ||
Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. | Q52039837 | ||
Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age. | Q53083052 | ||
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives? | Q58863213 | ||
Structural elucidation of the Cys-His-Glu-Asn proteolytic relay in the secreted CHAP domain enzyme from the human pathogenStaphylococcus saprophyticus | Q27652649 | ||
Structural Characterization of Inhibitors with Selectivity against Members of a Homologous Enzyme Family | Q27675312 | ||
A Molecular Mechanism for Bacterial Susceptibility to Zinc | Q27675498 | ||
Synthesis and structural characterisation of selective non-carbohydrate-based inhibitors of bacterial sialidases | Q27682822 | ||
Whole-genome random sequencing and assembly of Haemophilus influenzae Rd | Q27860765 | ||
Penicillin-binding proteins and beta-lactam resistance | Q28267300 | ||
Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species | Q28274570 | ||
Vaccines in the era of genomics: the pneumococcal challenge | Q28290283 | ||
The key role of genomics in modern vaccine and drug design for emerging infectious diseases | Q28476274 | ||
Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease | Q28579383 | ||
alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci | Q28910377 | ||
Incidence and outcomes of acute lung injury | Q29615139 | ||
Peptidoglycan structure and architecture | Q29617858 | ||
A functional genomic analysis of type 3 Streptococcus pneumoniae virulence | Q30669898 | ||
Differential fluorescence induction analysis of Streptococcus pneumoniae identifies genes involved in pathogenesis | Q30815520 | ||
Flamingo cadherin: a putative host receptor for Streptococcus pneumoniae | Q30831428 | ||
Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse | Q33208122 | ||
Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies | Q33312893 | ||
Architecture of peptidoglycan: more data and more models | Q33522829 | ||
Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae | Q33707018 | ||
The promise of immunoprophylaxis for prevention of acute otitis media | Q33756671 | ||
T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization | Q33820413 | ||
Reverse vaccinology, a genome-based approach to vaccine development | Q33938845 | ||
Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae | Q34003306 | ||
Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection | Q34006372 | ||
Nasopharyngeal colonization and invasive disease are enhanced by the cell wall hydrolases LytB and LytC of Streptococcus pneumoniae | Q34008872 | ||
Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae | Q34033151 | ||
Carbonic anhydrase is essential for Streptococcus pneumoniae growth in environmental ambient air. | Q34045574 | ||
Nosocomial bacterial meningitis | Q34092642 | ||
Streptococcus pneumoniae in biofilms are unable to cause invasive disease due to altered virulence determinant production | Q34103322 | ||
Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin a encapsulated in microspheres. | Q34120517 | ||
Characterization of pit, a Streptococcus pneumoniae iron uptake ABC transporter | Q34127364 | ||
A functional genomics approach to establish the complement of carbohydrate transporters in Streptococcus pneumoniae | Q34200747 | ||
Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence | Q34334220 | ||
Pneumococcal surface adhesin A (PsaA): a review | Q37279975 | ||
Microarray analysis of pneumococcal gene expression during invasive disease | Q37523378 | ||
Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period | Q37687485 | ||
New understandings on the pathophysiology of bacterial meningitis | Q37705951 | ||
Carbon metabolism of intracellular bacterial pathogens and possible links to virulence | Q37746934 | ||
Proteome analysis of host-pathogen interactions: Investigation of pathogen responses to the host cell environment | Q37895209 | ||
The top five "game changers" in vaccinology: toward rational and directed vaccine development | Q37911523 | ||
Bacterial transcriptomics: what is beyond the RNA horiz-ome? | Q37916225 | ||
Combat pneumococcal infections: adhesins as candidates for protein-based vaccine development | Q37972165 | ||
Impact of pneumococcal microbial surface components recognizing adhesive matrix molecules on colonization | Q38023604 | ||
Opposite effects of Mn2+ and Zn2+ on PsaR-mediated expression of the virulence genes pcpA, prtA, and psaBCA of Streptococcus pneumoniae | Q38290437 | ||
Regulation of glutamine and glutamate metabolism by GlnR and GlnA in Streptococcus pneumoniae. | Q38312175 | ||
Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway | Q38335915 | ||
Molecular analysis of the psa permease complex of Streptococcus pneumoniae. | Q38338881 | ||
Aspects of pneumococcal infection including bacterial virulence, host response and vaccination | Q38615152 | ||
Emergence of Multiply Resistant Pneumococci | Q39209668 | ||
Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection | Q39529421 | ||
Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice | Q39656547 | ||
The interaction of Streptococcus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage | Q39947404 | ||
E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae | Q40148762 | ||
Pneumococcal 6-phosphogluconate-dehydrogenase, a putative adhesin, induces protective immune response in mice | Q40288432 | ||
Impact of Glutamine Transporters on Pneumococcal Fitness under Infection-Related Conditions | Q34484667 | ||
The airway epithelium: soldier in the fight against respiratory viruses | Q34491598 | ||
Modifications to the peptidoglycan backbone help bacteria to establish infection | Q34529521 | ||
Viral and bacterial interactions in the upper respiratory tract | Q34550727 | ||
Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries | Q34609380 | ||
Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types | Q34681065 | ||
Interplay between manganese and zinc homeostasis in the human pathogen Streptococcus pneumoniae | Q34702482 | ||
Immunization with native or recombinant Streptococcus pneumoniae neuraminidase affords protection in the chinchilla otitis media model | Q34760226 | ||
Iron acquisition by Gram-positive bacterial pathogens | Q34935244 | ||
Identification of a Candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease | Q34975633 | ||
Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice | Q34975824 | ||
Next generation pneumococcal vaccines | Q35028495 | ||
Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease | Q35191900 | ||
Metabolic networks in motion: 13C-based flux analysis | Q35194034 | ||
Microbial metabolomics | Q35228780 | ||
From nose to lung: the regulation behind Streptococcus pneumoniae virulence factors | Q35586146 | ||
Streptococcus pneumoniae colonisation: the key to pneumococcal disease | Q35681330 | ||
Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. | Q35689099 | ||
Eukaryotic-type serine/threonine protein kinase StkP is a global regulator of gene expression in Streptococcus pneumoniae | Q35879288 | ||
Control of cell division in Streptococcus pneumoniae by the conserved Ser/Thr protein kinase StkP | Q35889373 | ||
Mass spectrometry in metabolome analysis. | Q35897249 | ||
ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies | Q35959243 | ||
Translational research in infectious disease: current paradigms and challenges ahead | Q35992621 | ||
Identification of genes that contribute to the pathogenesis of invasive pneumococcal disease by in vivo transcriptomic analysis | Q36163091 | ||
Versatility of pneumococcal surface proteins | Q36377374 | ||
Inhibitors of cysteine proteases | Q36447428 | ||
Site-specific contributions of glutamine-dependent regulator GlnR and GlnR-regulated genes to virulence of Streptococcus pneumoniae | Q36483583 | ||
Interplay between manganese and iron in pneumococcal pathogenesis: role of the orphan response regulator RitR | Q36558757 | ||
Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies | Q36558990 | ||
Pneumococcal resistance to antibiotics | Q36636190 | ||
The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease | Q37109940 | ||
Influences of capsule on cell shape and chain formation of wild-type and pcsB mutants of serotype 2 Streptococcus pneumoniae. | Q37191467 | ||
Detection of Streptococcus pneumoniae strain cocolonization in the nasopharynx | Q37214137 | ||
Phosphoproteomics in bacteria: towards a systemic understanding of bacterial phosphorylation networks | Q37257668 | ||
P433 | issue | 9 | |
P921 | main subject | metabolomics | Q12149006 |
pneumococcal vaccine | Q14538008 | ||
P304 | page(s) | 1061-1075 | |
P577 | publication date | 2013-09-01 | |
P1433 | published in | Expert Review of Vaccines | Q15756339 |
P1476 | title | Exploitation of physiology and metabolomics to identify pneumococcal vaccine candidates | |
P478 | volume | 12 |